Radiopharm Theranostics Limited

Radiopharm Theranostics Limitedverified

RADX

Price:

$4.27

Market Cap:

$47.30M

Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions. The company's diverse pipeline features: RAD 204, designed to target PD-L1 for non-small cell lung cancer; RAD 202, aimed at HER2 for breast cancer and other solid tumor types; and two avß6 integrin-targeting agents, RAD 301 (a diagnostic tool for pancreatic ductal adenocarcinoma) and RAD 302 (a therapeutic agent for various cancers...[Read more]

Industry

Biotechnology

IPO Date

2024-12-05

Stock Exchange

NASDAQ

Ticker

RADX

The PE Ratio as of June 2026 (TTM) for Radiopharm Theranostics Limited (RADX) is -1.15

According to Radiopharm Theranostics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.15. This represents a change of 154.26% compared to the average of -0.45 of the last 4 quarters.

Radiopharm Theranostics Limited (RADX) Historical PE Ratio (quarterly & annually)

How has RADX PE Ratio performed in the past?

The mean historical PE Ratio of Radiopharm Theranostics Limited over the last ten years is -41.54. The current -1.15 PE Ratio has changed 176.82% with respect to the historical average. Over the past ten years (40 quarters), RADX's PE Ratio was at its highest in in the December 2024 quarter at -0.12. The PE Ratio was at its lowest in in the December 2020 quarter at -102.02.

Quarterly (TTM)
Annual

Average

-41.54

Median

-1.23

Minimum

-204.05

Maximum

-0.31

Radiopharm Theranostics Limited (RADX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Radiopharm Theranostics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 308.13%

Maximum Annual PE Ratio = -0.31

Minimum Annual Increase = -99.40%

Minimum Annual PE Ratio = -204.05

Quarterly (TTM)
Annual
YearPE RatioChange
2025-1.25308.13%
2024-0.31-65.05%
2023-0.88-28.98%
2022-1.23-99.40%

Radiopharm Theranostics Limited (RADX) Average PE Ratio

How has RADX PE Ratio performed in the past?

The current PE Ratio of Radiopharm Theranostics Limited (RADX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.81

5-year avg

-41.54

10-year avg

-41.54

Radiopharm Theranostics Limited (RADX) PE Ratio vs. Peers

How is RADX’s PE Ratio compared to its peers?

Radiopharm Theranostics Limited’s PE Ratio is less than Alaunos Therapeutics, Inc. (-1.07), greater than Impact BioMedical Inc. (-4.90), less than Quoin Pharmaceuticals, Ltd. (-0.70), less than NovaBay Pharmaceuticals, Inc. (0.05), less than Brainstorm Cell Therapeutics Inc. (-0.86), less than Cardio Diagnostics Holdings, Inc. (-0.84), less than Addex Therapeutics Ltd (-0.87), less than Matinas BioPharma Holdings, Inc. (-0.45), less than Pasithea Therapeutics Corp. (-0.21), greater than Cyclerion Therapeutics, Inc. (-2.59),

Build a custom stock screener for Radiopharm Theranostics Limited (RADX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Radiopharm Theranostics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Radiopharm Theranostics Limited (RADX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Radiopharm Theranostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Radiopharm Theranostics Limited's PE Ratio?

How is the PE Ratio calculated for Radiopharm Theranostics Limited (RADX)?

What is the highest PE Ratio for Radiopharm Theranostics Limited (RADX)?

What is the 3-year average PE Ratio for Radiopharm Theranostics Limited (RADX)?

What is the 5-year average PE Ratio for Radiopharm Theranostics Limited (RADX)?

How does the current PE Ratio for Radiopharm Theranostics Limited (RADX) compare to its historical average?